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Malaria is one of the most epidemic infectious diseases
in the world affecting millions of patients and causing
more than 500,000 deaths each year. Although there are
several established antimalarials in clinical use, there is
an urgent need for new drugs due to rapid resistance
development. In recent years, more than 20,000 hits
phenotypically active against P. falciparum, one of the
major malaria causing agents, were disclosed from three
independent HTS campaigns [1-3]. In order to make these
hit libraries accessible to as many biological laboratories as
possible, the MMV compiled and distributed the Open
Access Malaria Box, a set of 400 chemically diverse active
compounds [4]. One important task is now to elucidate
the mode of action of those compounds. However, beside
the parasite targets it is also necessary to identify potential
host interactions in order to anticipate the risk of unde-
sired side effects of those chemotypes at the earliest possi-
ble stage of development.
To this end, we applied a ligand-based virtual target pro-
filing approach to predict possible interactions with
human targets [5]. Amongst others, kinases and GPCRs
were identified as the most important target classes. Sub-
sequently, several hundred predicted interactions were
selected for prospective experimental testing. Results
showed that a substantial part of the Malaria Box exhibits
the potential of interacting with human GPCRs. To this
extent, this was unexpected beforehand since the patho-
genic agent does not contain any GPCRs. In this respect,
particular attention was given to 5-HT2B receptor agon-
ism, an effect associated to cardiac valvulopathy [6].
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